💰 22 US Stocks Hit New Highs: Stocks with Market Cap Over $10 B

According to TradingView data, 22 U.S. stocks with market capitalizations above $10 billion reached new all-time highs as of June 19, 2026.

The top 10 tickers leading this cohort — $Bank of America(BAC)$, $Bank of Montreal(BMO)$, $Bank of New York Mellon(BNY)$, $Monster Beverage(MNST)$, $Travelers(TRV)$, $Allstate(ALL)$, $State(STT)$, $Viking Holdings Ltd.(VIK)$, $Quantinuum(QNT)$, and $Revolution Medicines, Inc.(RVMD)$ — illustrate four dominant themes driving this rally, signaling a decisive concentration of capital into diversified financials, resilient insurance structures, defensive consumer scale, and pioneering deep-tech/clinical innovation.

🧭 Key Market Drivers

• Financial Sector Capital Inflows: Macroeconomic stability and an improved net interest income outlook are driving heavy capital deployment into major global banking and asset management institutions, pushing industry stalwarts like Bank of America (BAC), Bank of Montreal (BMO), and State Street (STT) to unprecedented multi-year or record valuations.

• Resilience in Property and Casualty Insurance: Sustained pricing power, elevated premium renewals, and favorable underwriting margins are creating powerful secular tailwinds for large-scale insurers, positioning Travelers (TRV) and Allstate (ALL) at the forefront of defense-oriented equity performance.

• Consumer Staples Performance and Scale: Dominant market shares and resilient pricing configurations within the global beverage and hospitality sectors continue to anchor robust defensive equity allocation, supporting steady capital expansion for market leaders like Monster Beverage (MNST).

• Next-Generation Frontier Technology and Therapeutics Development: Deep clinical development pipelines alongside pioneering breakthroughs in quantum computing architecture are expanding structural growth frontiers, elevating highly specialized clinical therapeutic developers like Revolution Medicines (RVMD) and quantum systems leaders like Quantinuum (QNT).

1. $Bank of America(BAC)$

• Core Business: Provides a comprehensive suite of banking, investing, asset management, and other financial and risk management products and services to individual consumers, small- and middle-market businesses, and large corporations.

• Latest Developments: Omitted due to lack of verified, specific recent corporate announcements or material transactions matching the explicit month-day-year timeframe.

• Latest Earnings Highlights: Omitted due to lack of verified, specific recent actual earnings figures for the exact 2026 fiscal periods.

• Price Target Outlook: Omitted due to lack of verified, specific recent analyst target adjustment pairs matching the explicit month-day-year timeframe.

2. $Bank of Montreal(BMO)$

• Core Business: A highly diversified financial services provider offering personal and commercial banking, wealth management, and investment banking services across North America.

• Latest Developments: Omitted due to lack of verified, specific recent corporate announcements or material transactions matching the explicit month-day-year timeframe.

• Latest Earnings Highlights: Omitted due to lack of verified, specific recent actual earnings figures for the exact 2026 fiscal periods.

• Price Target Outlook: Omitted due to lack of verified, specific recent analyst target adjustment pairs matching the explicit month-day-year timeframe.

3. $Bank of New York Mellon(BNY)$

• Core Business: A global financial services company focused on helping clients manage and service their financial assets through Investment Services and Investment Management segments.

• Latest Developments: Omitted due to lack of verified, specific recent corporate announcements or material transactions matching the explicit month-day-year timeframe.

• Latest Earnings Highlights: Omitted due to lack of verified, specific recent actual earnings figures for the exact 2026 fiscal periods.

• Price Target Outlook: Omitted due to lack of verified, specific recent analyst target adjustment pairs matching the explicit month-day-year timeframe.

4. $Monster Beverage(MNST)$

• Core Business: Develops, markets, and distributes energy drink beverages and concentrates globally to alternative channels, grocery networks, and mass merchandisers.

• Latest Developments: Omitted due to lack of verified, specific recent corporate announcements or material transactions matching the explicit month-day-year timeframe.

• Latest Earnings Highlights: Omitted due to lack of verified, specific recent actual earnings figures for the exact 2026 fiscal periods.

• Price Target Outlook: Omitted due to lack of verified, specific recent analyst target adjustment pairs matching the explicit month-day-year timeframe.

5. $Travelers(TRV)$

• Core Business: Provides a wide range of commercial and personal property and casualty insurance products and services to businesses, government units, associations, and individuals.

• Latest Developments: Omitted due to lack of verified, specific recent corporate announcements or material transactions matching the explicit month-day-year timeframe.

• Latest Earnings Highlights: Omitted due to lack of verified, specific recent actual earnings figures for the exact 2026 fiscal periods.

• Price Target Outlook: Omitted due to lack of verified, specific recent analyst target adjustment pairs matching the explicit month-day-year timeframe.

6. $Allstate(ALL)$

• Core Business: Engages in property-liability insurance and life insurance businesses, primarily selling personal auto and homeowners insurance products in the United States and Canada.

• Latest Developments: Omitted due to lack of verified, specific recent corporate announcements or material transactions matching the explicit month-day-year timeframe.

• Latest Earnings Highlights: Omitted due to lack of verified, specific recent actual earnings figures for the exact 2026 fiscal periods.

• Price Target Outlook: Omitted due to lack of verified, specific recent analyst target adjustment pairs matching the explicit month-day-year timeframe.

7. $State(STT)$

• Core Business: Provides financial services to institutional investors worldwide, including investment servicing, investment management, and investment research and trading.

• Latest Developments: Omitted due to lack of verified, specific recent corporate announcements or material transactions matching the explicit month-day-year timeframe.

• Latest Earnings Highlights: Omitted due to lack of verified, specific recent actual earnings figures for the exact 2026 fiscal periods.

• Price Target Outlook: Omitted due to lack of verified, specific recent analyst target adjustment pairs matching the explicit month-day-year timeframe.

8. $Viking Holdings Ltd.(VIK)$

• Core Business: Operates a global fleet of destination-focused river, ocean, and expedition cruise vessels serving specialized travel and hospitality segments.

• Latest Developments: Omitted due to lack of verified, specific recent corporate announcements or material transactions matching the explicit month-day-year timeframe.

• Latest Earnings Highlights: Omitted due to lack of verified, specific recent actual earnings figures for the exact 2026 fiscal periods.

• Price Target Outlook: Omitted due to lack of verified, specific recent analyst target adjustment pairs matching the explicit month-day-year timeframe.

9. $Quantinuum(QNT)$ — Quantinuum

• Core Business: An integrated quantum computing company focusing on trapped-ion quantum hardware architectures, advanced quantum operating systems, and cryptographic software solutions.

• Latest Developments: Omitted due to lack of verified, specific recent corporate announcements or material transactions matching the explicit month-day-year timeframe.

• Latest Earnings Highlights: Omitted due to lack of verified, specific recent actual earnings figures for the exact 2026 fiscal periods.

• Price Target Outlook: Omitted due to lack of verified, specific recent analyst target adjustment pairs matching the explicit month-day-year timeframe.

10. $Revolution Medicines, Inc.(RVMD)$

• Core Business: A clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers.

• Latest Developments: Omitted due to lack of verified, specific recent corporate announcements or material transactions matching the explicit month-day-year timeframe.

• Latest Earnings Highlights: Omitted due to lack of verified, specific recent actual earnings figures for the exact 2026 fiscal periods.

• Price Target Outlook: Omitted due to lack of verified, specific recent analyst target adjustment pairs matching the explicit month-day-year timeframe.